Keith Zullow, a partner in Goodwin's IP Litigation group, is a U.S. registered patent attorney with significant trial experience in chemical and pharmaceutical patent litigation. He is also experienced in interference practice and trade secret litigation. Mr. Zullow has worked on cases in various federal district courts throughout the United States, on appeals before the U.S. Court of Appeals for the Federal Circuit and other circuit courts, and is lead counsel on proceedings before the Patent Trial and Appeal Board.
In recent years, Mr. Zullow has served as trial counsel in pharmaceutical patent litigation for companies including Roxane Laboratories, West-Ward Pharmaceuticals and Teva Pharmaceuticals USA, and was lead counsel in a damages hearing. Some of his highlights include the following:
Other recent engagements include the following:
Before joining Goodwin, Mr. Zullow was an associate at Fish & Neave, where his work focused on intellectual property litigation, trade secret litigation, interference practice and patent prosecution for clients including ExxonMobil Chemical Company, Hoechst Celanese, Aventis Pharmaceuticals, The Gillette Company and Phelps Dodge.
Mr. Zullow recently contributed to Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed., published by Thomson Reuters in November 2019
Mr. Zullow recently presented on Life Sciences Transactions at PLI’s Program titled: “IP Issues in Business Transactions 2018.”
Mr. Zullow recently chaired PLI’s “Understanding Patent Law 2018” program and presented on the Patent Landscape.
Mr. Zullow published a June 20, 2018 article in BNA’s Patent, Trademark & Copyright Journal titled “INSIGHT: The Ongoing Debate About Disclosing Manufacturing Process Information in the Patent Dance.”
Mr. Zullow published an article in the May 2018 edition of Intellectual Property Magazine, titled “Turning tide on diagnostic method claims.”
Mr. Zullow published a series of articles examining patent issues related to plants and seeds in Cereal Foods World, which included:
(with distinction)
Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。